MSH2 and renal pelvis/ureter urothelial carcinoma: The most common pattern of MMRP loss observed in IHC screening of UTUC tumors was a combination of MSH2 and MSH6, followed by MSH2 alone, MSH6 alone, and a combination of MLH1 and PMS2 [16].